Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Randall A Oyer"'
Autor:
Anna C. Raper, Benita L. Weathers, Theodore G. Drivas, Colin A. Ellis, Colleen Morse Kripke, Randall A. Oyer, Anjali T. Owens, Anurag Verma, Paul E. Wileyto, Colin C. Wollack, Wenting Zhou, Marylyn D. Ritchie, Robert A. Schnoll, Katherine L. Nathanson
Publikováno v:
Implementation Science, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Germline genetic testing is recommended for an increasing number of conditions with underlying genetic etiologies, the results of which impact medical management. However, genetic testing is underutilized in clinics due to system,
Externí odkaz:
https://doaj.org/article/74eb2115f4614d7abd18eefde9e0794d
Autor:
Kelsey S. Lau-Min, Lisa A. Varughese, Maria N. Nelson, Christine Cambareri, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Pharmacogenetic (PGx) testing for germline variants in the DPYD and UGT1A1 genes can be used to guide fluoropyrimidine and irinotecan dosing, respectively. Despite the known association between PGx variants and chemotherapy toxici
Externí odkaz:
https://doaj.org/article/8056029013234379a4bfba137431d963
Autor:
Lisa A. Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, Shannon Terek, Margaret Harr, Hakon Hakonarson, Christine Cambareri, Jessica Marini, Jeffrey Landgraf, Jinbo Chen, Genevieve Kanter, Kelsey S. Lau-Min, Ryan C. Massa, Nevena Damjanov, Nandi J. Reddy, Randall A. Oyer, Ursina R. Teitelbaum, Sony Tuteja
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundFluoropyrimidines (fluorouracil [5-FU], capecitabine) and irinotecan are commonly prescribed chemotherapy agents for gastrointestinal (GI) malignancies. Pharmacogenetic (PGx) testing for germline DPYD and UGT1A1 variants associated with red
Externí odkaz:
https://doaj.org/article/9516907262044f3197382352e2d55e3c
Autor:
Carmen Guerra, Alice Pressman, Patricia Hurley, Elizabeth Garrett-Mayer, Suanna S. Bruinooge, Alexandra Howson, Melinda Kaltenbaugh, Jen Hanley Williams, Leigh Boehmer, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Lola Fashoyin-Aje, Worta McCaskill-Stevens, Janette Merrill, Greg Nowakowski, Manali I. Patel, Amelie Ramirez, Victoria Zwicker, Randall A. Oyer, Lori J. Pierce
Publikováno v:
JCO Oncology Practice. 19:e581-e588
Clinical trial participants do not reflect the racial and ethnic diversity of people with cancer. ASCO and the Association of Community Cancer Centers collaborated on a quality improvement study to enhance racial and ethnic equity, diversity, and inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dea9a6fb2441cde121eccb67299e947
https://doi.org/10.1200/op.22.00560
https://doi.org/10.1200/op.22.00560
Autor:
Nadine J. Barrett, Leigh Boehmer, Janelle Schrag, Al B. Benson, Sybil Green, Leila Hamroun-Yazid, Alexandra Howson, Khalid Matin, Randall A. Oyer, Lori Pierce, Sanford E. Jeames, Karen Winkfield, Eddy S. Yang, Victoria Zwicker, Suanna Bruinooge, Patricia Hurley, Jen Hanley Williams, Carmen E. Guerra
Publikováno v:
JCO Oncology Practice. 19:e570-e580
PURPOSE: Cancer trial participants do not reflect the racial and ethnic diversity in the population of people with cancer in the United States. As a result of multiple system-, patient-, and provider-level factors, including implicit bias, cancer cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f7b3bf5b802799edef2f314c7b5f897
https://doi.org/10.1200/op.22.00378
https://doi.org/10.1200/op.22.00378
Autor:
Randall A. Oyer, Patricia Hurley, Leigh Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine Barrett, Al Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Kyle DeLeon, Lola Fashoyin-Aje, Elizabeth Garrett-Mayer, Julie R. Gralow, Sybil Green, Carmen E. Guerra, Leila Hamroun, Claudia M. Hardy, Bridgette Hempstead, Sanford Jeames, Mel Mann, Khalid Matin, Worta McCaskill-Stevens, Janette Merrill, Grzegorz S. Nowakowski, Manali I. Patel, Alice Pressman, Amelie G. Ramirez, Juanita Segura, Barbara Segarra-Vasquez, Jen Hanley Williams, James E. Williams, Karen M. Winkfield, Eddy S. Yang, Victoria Zwicker, Lori J. Pierce
Publikováno v:
Journal of Clinical Oncology. 40:2163-2171
A concerted commitment across research stakeholders is necessary to increase equity, diversity, and inclusion (EDI) and address barriers to cancer clinical trial recruitment and participation. Racial and ethnic diversity among trial participants is k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b451dc6b944f2faba50434a9cebf566a
https://doi.org/10.1200/jco.22.00754
https://doi.org/10.1200/jco.22.00754
Autor:
Christa, Braun-Inglis, Leigh M, Boehmer, Laura J, Zitella, Brianna, Hoffner, Yurii B, Shvetsov, Jeffrey L, Berenberg, Randall A, Oyer, Al B, Benson
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:107-119
Background: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance value across
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edeee281dc29eaac4bc8d64f7419cefb
https://doi.org/10.6004/jadpro.2022.13.2.2
https://doi.org/10.6004/jadpro.2022.13.2.2
Autor:
Randall A. Oyer, Christopher S. Lathan, Matthew P. Smeltzer, Amanda Kramar, Leigh M. Boehmer, Thomas M. Asfeldt
Publikováno v:
Oncology Issues. 36:70-78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bee9a1cb07c76a3e398e2ac148a4f0eb
https://doi.org/10.1080/10463356.2021.1930441
https://doi.org/10.1080/10463356.2021.1930441
Autor:
Divij Mathew, Laura A. Vella, Randall A. Oyer, Jedd D. Wolchok, James Robinson, Cécile Alanio, Susan DeWolf, Kara N. Maxwell, Amy E. Baxter, Erin Bange, Karan Naik, Scott E. Hensley, Justin Kim, Anita Kumar, Tara Perloff, Adam J Widman, Madison E. Weirick, Santosha Vardhana, Madeline A Hwee, Florence Porterfield, Derek A. Oldridge, Krista R Budzik, Samuel J Kerr, Justine V. Cohen, Nicholas Han, Josephine R. Giles, Christopher M McAllister, Ariel R. Weisman, Michael Galantino, Angela DeMichele, Ivan Maillard, Charlotte Roberts, Caroline A. G. Ittner, Paul Wileyto, Ronac Mamtani, Lova Sun, Susan Tollett, Jennifer E. Wu, Olutosin Owoyemi, Sharon Adamski, John P. Reilly, Alexander C. Huang, Sigrid Gouma, Ryan Massa, Allison R. Greenplate, Sawsan R. Boutemine, E. John Wherry, Heather M. Giannini, Tiffanie K. Jones, Carla Wright, Olutwatosin Oniyide, Emily M. Kugler, N. Esther Babady, Alfred L. Garfall, Peter Maslak, Robert H. Vonderheide, Cathy Zheng, R.S. Agyekum, Nuala J. Meyer, Thomas G. Dunn
Publikováno v:
Nature Medicine. 27:1280-1289
Patients with cancer have high mortality from coronavirus disease 2019 (COVID-19), and the immune parameters that dictate clinical outcomes remain unknown. In a cohort of 100 patients with cancer who were hospitalized for COVID-19, patients with hema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::953c384aa17e1a2d15af5f6dd7fec305
https://doi.org/10.1038/s41591-021-01386-7
https://doi.org/10.1038/s41591-021-01386-7
Publikováno v:
JCO Oncology Practice. 17:215-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c4115638dfd639e0b4b4bb8fc5e83e
https://doi.org/10.1200/op.20.00895
https://doi.org/10.1200/op.20.00895